Despite substantial recent progress (reviewed in Hubbard and Sinclair, 2014), many key questions remain in this area.
sirtfood science sirtuin diet history looking RSV has been reported to extend longevity in yeast, worms, flies, and short-lived fish (Baur, 2010b); in mammals, RSV supplementation rescues the shortened lifespan of mice on a HFD (Baur et al., 2006). By continuing you agree to the use of cookies. To date, several epigenetic modifiers are in the market or currently under clinical trial, including HDAC inhibitors (HDACi), HAT inhibitors (HATi), protein arginine methyltransferase inhibitors (PRMTis), DNA methyltransferase inhibitors (DNMTis), histone demethylating inhibitors (HDMis), and sirtuin-activating compounds (STACs) [97]. This study also reported that SRT1460 and SRT3025 were effective in inhibiting the growth and survival of pancreatic cancer. L. Raffaghello, V. Longo, in International Review of Cell and Molecular Biology, 2017. UBCS039 was reported to activate SIRT6 activities without affecting its expression level regardless of cancer histotype [287]. Pharmacological mechanisms of sirtuin modulation.
NAD+ bioavailability is reduced in disease states and aging.89 A precursor of NAD+, nicotinamide, is being evaluated as a therapy to correct NAD+ deficiency and improve sirtuin activity. This was also seen with pharmacologic PARP inhibition in vitro and in vivo [269]. Epigenetic drugs or nucleoside-like compounds such as DNA methylation inhibitors, e.g., histone acetyltransferases (HATs) and histone deacetylases (HDACs), have been evaluated and approved for the treatment of certain cancers [96].
A first meta-analysis of six studies regarding resveratrol supplementation showed statistically significant positive effects on systolic BP, hemoglobin A1c, creatinine, but not on fasting glucose, homeostatic model assessment of insulin resistance, diastolic BP, or lipid profiles [90].
The efficacy of resveratrol is limited by its poor bioavailability and low potency. sirt1 assay fluorometric inhibitor sirtuin activators sirt inhibitors abcam
Thus, targeting epigenetic modifications, especially HDAC, could delay the progression of a hyperglycemic state and the onset of diabetic complications. PARP inhibitors have been developed and show benefit in BRCA- or HR-deficient cancers. Promising CR mimetics with properties of cardiovascular protection include compounds that intersect with the critical signaling pathways identified above. Jana Nano, Taulant Muka, in Epigenetics in Human Disease (Second Edition), 2018. These RSV-induced phenotypes are SIRT1-dependent, though at a higher dose RSV does not require functional SIRT1 to activate AMPK (Price et al., 2012). Epigenetic modifications, unlike genetic changes, are usually reversible. Synthetic STACS have also been demonstrated to exert beneficial cardiovascular effects on healthy cigarettes smokers (Venkatasubramanian et al., 2013).
Activation of Sirt6-dependent deacetylation can be achieved with fatty acids, and competition experiments implicated the enzymes long acyl-binding channel as a binding site.35 This activating effect required several hundred M fatty acid concentrations, however, and only more recently, pyrrolo[1,2-a]quinoxaline-derived compounds were discovered as first potent Sirt6 activators.36 These compounds increase Sirt6-dependent deacetylation of peptide substrates, histone proteins, and complete nucleosomes. Iachettini and colleagues reported that UBCS039-mediated activation of autophagy was strictly dependent on SIRT6 deacetylating activity. Given their beneficial effects in promoting longevity, sirtuin family proteins are a very interesting drug target. A considerable amount of data has accumulated on treating humans with potential STACs with inconclusive results [9093]. In this regard, a specific amino acid in SIRT1 required for STAC-mediated activation has recently been identified. These questions are worth pursuing in phase 1 clinical trials. Also, mice lacking the NAD+-consuming enzyme CD38 have increased cellular NAD+ and SIRT1 activity in several metabolically active tissues (Barbosa et al., 2007). Another strategy to modulate sirtuin activity in hematologic malignancies is by inhibiting endogenous breakdown of NAD+.
Two opposing models have been proposed to account for STAC activity: (1) direct allosteric activation of SIRTs through the lowering of peptide substrate Km, and/or (2) indirect activation resulting from off-target effects [258261].
Based on the earlier studies of sirtuin 1 and its activation by resveratrol, a number of small molecule SIRT1 activators have been synthesized and are currently being tested.63 Sirtuin-activating compounds (STACs) exert their effect by allosteric activation of this deacetylase. For example, in a mouse model of T2D, NMN supplementation mitigates negative metabolic effectsinsulin insensitivity, glucose intolerance, and inflammationof age-related or diet-induced diabetes, potentially due to the activation of SIRT1 and other sirtuins, and their downstream target pathways (Yoshino et al., 2011). One difficulty with the use of RSV in vivo is that it has significant off-target effects (Baur, 2010a). However, SRT2104 has been limited by poor and variable pharmacokinetics after oral intake. Reduced NAD+ levels induced by advanced age, caloric excess, or a sedentary lifestyle would impair activity of sirtuins and other NAD+-dependent cellular processes. markus maute ageing
As research on SIRTs progressed over the years, synthetic STACs were also developed. In mouse studies, flavonoids (e.g., quercetin, apigenin, and luteolindin) and thiazoloquin(az)olinones inhibit CD38 and cause an increase in NAD+ levels [266268]. Although increased evidence indicates RSV to be an effective SIRT1 activator with anticancer properties, its poor solubility, low bioavailability, rapid elimination, and unwanted toxicity effects are the major factors that limit its development as a cancer drug candidate [281].
To date, several epigenetic modifiers are in the market or currently under clinical trial, including HDAC inhibitors (HDACi), HAT inhibitors (HATi), protein arginine methyltransferase inhibitors (PRMTis), DNA methyltransferase inhibitors (DNMTis), histone demethylating inhibitors (HDMis), and. ScienceDirect is a registered trademark of Elsevier B.V. ScienceDirect is a registered trademark of Elsevier B.V. Complementary and Alternative Therapies and the Aging Population, Pharmacological Approaches for Modulating Sirtuins, Introductory Review on Sirtuins in Biology, Aging, and Disease, The bifunctional roles of sirtuins and their therapeutic potential in cancer, Sirtuin Biology in Cancer and Metabolic Disease, Sirtuins, Healthspan, and Longevity in Mammals, Handbook of the Biology of Aging (Eighth Edition), High-throughput screens have been conducted to identify small molecule, Baur and Sinclair, 2006; Kaeberlein et al., 2005; Pacholec et al., 2010; Park et al., 2012, Barger et al., 2008a,b; Pearson et al., 2008, Miller et al., 2011; Pearson et al., 2008, Baur and Sinclair, 2006; Kaeberlein et al., 2005; Pacholec et al., 2010, Metabolic Alterations at the Crossroad of Aging and Oncogenesis, International Review of Cell and Molecular Biology. Thus further evaluation of STACs activity in a cancer-specific manner is required. Next, the coadministration of a HDAC inhibitor with a sirtuin inhibitor results in synergy of their cytotoxicity in primary AML and CLL samples and the following cell lines: U937 (AML), 697 (pre-B-cell leukemia), and Jurkat (acute T-cell leukemia). In mice and nonhuman primates fed a high-fat diet, resveratrol protects against the effects of obesity and age-related metabolic decline, increases insulin sensitivity and mitochondrial functions, and prevents liver steatosis (Baur et al., 2006; Fiori et al., 2013; Jimenez-Gomez et al., 2013). These mice are highly resistant to weight gain in response to a HFD relative to controls.
These STACs activate SIRTs allosterically [235]. These compounds include biguanides such as metformin, which targets the AMPK and insulin signaling pathways; resveratrol, which partially affects sirtuin activity; and rapamycin, which interacts with mTOR signaling. Acetyl peptide (beige) and NAD+ (yellow) were modeled to indicate their binding sites. A number of clinical trials involving resveratrol showed benefits in glucose metabolism and cardiovascular disease risk factors [263,264], but many others have shown little to no benefits [265]. (C) Crystal structure of Sirt1 in complex with FdL peptide (beige) and three resveratrol molecules (cyan) around its fluorophore (PDB entry 4BTR).
sirtuin Ryan A. Denu, in Sirtuin Biology in Cancer and Metabolic Disease, 2021. A sustained activation of SIRT6 as a result of UBCS039 treatment also resulted in autophagy-related cell death [287]. The SIRT1-specific activator SRT1720 induces apoptosis of multiple myeloma cells [238].
5.2D).36 The structures together with first structureactivity relationship analyses indicate a key role in binding for the compounds pyridine substituents, which occupy a Sirt6 pocket that branches off from the acyl channel. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransfereases (NMNATs). It will be interesting to see how these affect sirtuin signaling in hematologic malignancies. Consistent with the observed binding mode, the compounds activate Sirt6 only against acetylated substrate and instead show competition against substrate carrying the longer myristoyl modification that requires these Sirt6 regions for binding, indicating the exciting possibility to develop acyl-specific Sirt6 modulators. Figure 6.2.
NAD+ is broken down by CD38, poly ADP-ribose polymerase 1 (PARP1), and sterile alpha and TIR motif containing protein 1 (SARM1). Therefore, targeting HDAC3 by developing an isoform-specific HDAC3 inhibitor might be an effective therapeutic intervention for diabetes and its complications, as well as inflammation [103]. Figure 3.6. Expression of SIRT1 was suppressed in these two cancer cell lines due to hypoxic stress, thus promoting EMT. Firstly regarding activators, the study of resveratrol sensitivity of cancer cell lines found a marked degree of variability based on cell type. Going through each of the seven sirtuins above, I have tried to highlight potential therapeutic opportunities. SRT2104 protects against experimentally induced muscle atrophy in wild-type mice, and muscle-specific Sirt1 knockdown in vivo accelerates muscle loss. In the setting of DNA damage, PARPs consume NAD+ to help repair DNA, but this probably reduces sirtuin activity. Huang et al. In mice, RSV treatment stimulates mitochondrial function, activates AMPK and increases NAD+ levels. Michael S. Goligorsky, in Kidney Transplantation, Bioengineering and Regeneration, 2017, The more traditional therapeutics acting on EPCs and endothelial cells belong to categories of ACE inhibitors, aldosterone inhibitors and statins, as has been exhaustively described in the past.46. Further investigation will need to discern the nature of their seemingly contradictory oncogenic and tumor-suppressive functions. (A) Crystal structure of Sirt5 in complex with FdL peptide (blue) and resveratrol (gray; PDB entry 4HDA). Promising CR mimetics with properties of cardiovascular protection include compounds that intersect with the critical signaling pathways identified above. PARP inhibitors increase NAD+ levels, which in theory could activate sirtuins.
There are two different types of STACs: natural and synthetic. NAD+ levels can be increased by providing NAD+ precursors via activation of NAD biosynthetic enzymes, or via inhibition of NAD hydrolase CD38. This study places SIRT1 upstream of AMPK activation and proposes a model of sustained sirtuin activation via RSV treatment that results in a net accumulation of NAD+. One caveat in interpreting any findings involving NAD+ modulation is that increased NAD+ levels may activate not only sirtuins, but also additional NAD+-dependent enzymes, such as PARP1.
sirtfood happier scientifically proven Moreover, vorinostat (THS-785 and ITF2357) has been shown to diminish IL-1b expression and to prevent -cell loss in diabetic settings [100,101]. The more commonly known synthetic STACs which are commercially available and reported to target cancer include SRT1720, SRT3025, SRT1460, SRT2183, and UBCS039 [235,267270]. RSV supplementation shifts the gene expression pattern observed in mice on a HFD toward a profile associated with a standard diet.
Although some mechanistic details still remain to be clarified, the first synthetic STACs have entered clinical trials for evaluation as therapeutic Sirt1 activators against inflammatory and metabolic disorders.26. An increase in the cellular NAD+/NADH ratio will increase sirtuin activity. Synthetic activators such as SRT1720 and SRT2104 improve the metabolic profile and extend life span and health span of mice under a high-fat and normal diet (Mitchell et al., 2014; Minor et al., 2011). Microarray analysis revealed that SRT2104 likely has anti-inflammatory properties in skeletal muscle tissue, evidenced by a decrease in expression of NF-B target genes. As many sirtuins have been shown to play tumor-suppressive roles, one might reason that chronic DNA damage over the life span, such as from smoking, UV light, and other environmental pollutants, may reduce sirtuin activity. Concerns have been raised as to whether these polyphenols actually directly activate SIRT1 (Baur and Sinclair, 2006; Kaeberlein et al., 2005; Pacholec et al., 2010; Park et al., 2012). It will be interesting to see how newer, more potent, and more orally bioavailable sirtuin modulators evolve.
These synthetic STACs are potent SIRT1 activators with 800- to 1000-fold efficacy compared to RSV [259,267]. Resveratrol also shows benefit in improving insulin sensitivity in nonhuman primates [259]. RSV has been found in many plants, such as cranberries, grapes, peanuts, and Japanese giant knotweed [271]. (B) Crystal structure of Sirt1 in complex with a STAC (cyan; PDB entry 4ZZH). Interestingly, the compounds show no effects against Sirt1, 2, and 3, as expected from the Sirt6-specific binding site, but stimulate Sirt5s desuccinylase activity.36 The molecular basis of this Sirt5 effect remains to be characterized, but it shows that the Sirt6 activators and the structures of Sirt6/activator complexes will now have to be exploited for further development to obtain highly specific Sirt6 modulators. This section will summarize preclinical and clinical studies of sirtuin modulators and discuss some of the most impactful future avenues of investigation.
NBMs supply precursors for NAD+ synthesis. Yeuan Ting Lee, Chern Ein Oon, in Sirtuin Biology in Cancer and Metabolic Disease, 2021. Besides, RSV has been shown to alleviate EMT processes in lung and ovarian cancer in vitro and in vivo [279,280].
NMN, NR supplementation, CR or physical activity increases cellular NAD+ levels. Given their beneficial effects in promoting longevity, sirtuin family proteins are a very interesting drug target. .
UBCS039 is a newly synthesized pyrrolo[1,2-a]quinoxaline derivative, the first synthetic SIRT6 activator [286]. STACs are allosteric modulators of SIRT1 that bind to a site on the protein other than the active site to induce a conformational change that increases the activity of the enzyme.
Modulating sirtuin activities could also be an area of prevention of hematologic malignancies.
Cells bearing a SIRT1 mutant at this site do not show the increased mitochondrial copy number and ATP content normally induced by STAC treatment (Hubbard et al., 2013).
Spermidine is a naturally occurring polyamine that is reported to counteract age-related hyperacetylation of histones due to age-dependent reduction in polyamine metabolism [98]. A Japanese epidemiologic study demonstrated that a polyamine-rich traditional Japanese food called fermented soybeans showed significant enhancement of polyamine concentration in the blood of the participants without any obvious adverse effects [101]. The increased availability of NAD+ and subsequent increased SIRT1 activity in the setting of PARP inhibition could result in greater repression of p53, which may partially reverse the efficacy of the PARP inhibitor. Pharmacological sirtuin activation. Copyright 2022 Elsevier B.V. or its licensors or contributors. This study also reported that RSV treatment induces autophagy through SIRT1/S6K pathways and inhibits the incidence of precursor lesions of prostate cancer through the Akt/mTOR signaling pathway [277].
In addition, resveratrol delays the onset of neurodegeneration and improves learning and memory in aged mice (Graff et al., 2013; Zhao et al., 2013). The in vivo study of MDL-800 in a HCC tumor xenograft model and in SIRT6 KO mice also demonstrated a significant impediment of tumor growth by activating the deacetylase activity of SIRT6 [288]. The sirtuin inhibitors tenovin-1 and tenovin-6 show activity in models of a number of hematologic malignancies, including ALL [37], DLBCL [257], and cutaneous T cell lymphoma [45]. Among these epigenetic modifiers, valproic acid, sodium phenylbutyrate, vorinostat, givinostat, and curcumin are HDACi; resveratrol is a STACs; AMI-1 is a PRMTis; tranylcypromine is part of HDMis; and hydralazine, procainamide, RG108, and MG98 belong to DNMTis [98]. In comparison, these drugs were poorly active in healthy PBMCs [52].
In contrast, two more recent meta-analysis on randomized controlled clinical studies failed to show beneficial effects on cardiovascular risk factors [91,92]. Additionally, treatment with SRT1720 synergizes with an inhibitor of the K3K79 methyltransferase, DOT1L, in mixed lineage leukemia (MLL)-rearranged leukemia cells [258]. Interestingly, there is evidence that modulating sirtuin activity could help prevent graft versus host disease (GVHD), one of the major and devastating complications associated with BMT. Dietary restriction, which induces SIRT1, acts via mTOR signaling and nicotine amide dinucleotide (NAD)dependent pathways accompanied by a shift toward oxidative metabolism,88 both representing novel modes of rejuvenation therapy. Another venue for rejuvenation therapy is based on the series of findings implicating mTOR activation and the resulting defect in autophagy in senescence.
An interesting question is how much of the carcinogenic effect of these exposures is conferred by the theoretical reduced sirtuin activity. Furthermore, another study also reported an enhanced effect when SRT1720 was used in combination with dexamethasone or bortezomib [269,283]. (A) STACs resveratrol and SRT1720; (B) NAD+ precursors nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN); (C) Potential nicotinamide phosphoribosyltransferase (NAMPT) activator P7C3 and CD38 inhibitor apigenin. Interestingly, the resveratrol effect on Sirt5 also depends on the acyl modification, since resveratrol activated Sirt5-dependent FdL deacetylation but inhibited Sirt5-dependent FdL desuccinylation.32. Alternatively, resveratrol may first activate sirtuin 1 in vivo, leading to AMPK activation via deacetylation and activation of the AMPK kinase LKB1 (Hou et al., 2008; Lan et al., 2008).
In the context of CD38-deficient mice, protection against weight gain was lost when animals were treated with a sirtuin inhibitor, implicating sirtuin activation in this effect. However, SRT1720 has also been reported to promote breast cancer metastasis [274], suggesting that the effects of STACs may function in the opposite manner. However, clinical trials to date have been less promising than the preclinical studies. Wang and colleagues have previously shown that in vivo SIRT1+/; p53+/ mice xenograft models with different malignancy types (i.e. A variety of stilbene derivatives with modifications at the 4 position of the B ring of resveratrol were synthesized that have lower toxicity and higher potency with respect to SIRT1 activation and lifespan extension in budding yeast, showing for the first time that it is possible to improve upon naturally occurring STACs.3. Known pharmacological agents that target these substrates and enzymes to increase NAD+ levels are marked on the figure in black, or indicated with gray arrows. STACs include, in addition to resveratrol, quercetin and butein (first generation); SRT 1720, 1460, and 2183 (second generation); and STAC-5, -9, and -10 (third generation), all extending life-span and/or health-span. Allosteric sirtuin activation with small molecules, with the goal of promoting healthspan and longevity, has been an area of intense investigation. Phenotypes resulting from increased NAD+ levels must be rigorously elucidated in model organisms before use of these non-allosteric approaches can be attempted in humans. The anticancer roles of RSV have been widely studied and indicate that RSV can inhibit tumorigenesis by inducing S-phase cell cycle arrest and apoptosis, as well as inhibiting metastasis, aromatase, and angiogenesis in liver, breast, prostate, leukemia, skin, and myeloma cancer cells [271,272].
Alternatively, synthetic STACs such as SRT2170 and SIRT1460 have been synthesized to overcome the RSV limitation. Moreover, in rhesus monkeys, under a high-fat and high-sugar diet, resveratrol exerts antiinflammatory effects in visceral white adipose tissue (Jimenez-Gomez et al., 2013). SIRT1 STACs, SRT2183, and SRT501 have demonstrated significant inhibition of growth and induction of apoptosis in malignant lymphoid cell lines. Also, SIRT1-dependent stimulation of osteogenic differentiation by SRT2104 treatment was reported using myoblast cell cultures, suggesting SRT2104 activates SIRT1 to protect against age-related muscle loss and osteoporosis. These studies initially identified resveratrol (RSV) and other polyphenols as SIRT1 activators (Howitz et al., 2003); subsequent studies have identified a large series of artificial, higher-potency STACs. In cancer, resveratrol for 45 weeks reduces prostate cancers by about 50% in mice [260].
This shift occurs in parallel with improved overall health, insulin sensitivity, increased mitochondrial content, and maintenance of motor function (Barger et al., 2008a,b; Pearson et al., 2008).


A first meta-analysis of six studies regarding resveratrol supplementation showed statistically significant positive effects on systolic BP, hemoglobin A1c, creatinine, but not on fasting glucose, homeostatic model assessment of insulin resistance, diastolic BP, or lipid profiles [90].
The efficacy of resveratrol is limited by its poor bioavailability and low potency. sirt1 assay fluorometric inhibitor sirtuin activators sirt inhibitors abcam
Thus, targeting epigenetic modifications, especially HDAC, could delay the progression of a hyperglycemic state and the onset of diabetic complications. PARP inhibitors have been developed and show benefit in BRCA- or HR-deficient cancers. Promising CR mimetics with properties of cardiovascular protection include compounds that intersect with the critical signaling pathways identified above. Jana Nano, Taulant Muka, in Epigenetics in Human Disease (Second Edition), 2018. These RSV-induced phenotypes are SIRT1-dependent, though at a higher dose RSV does not require functional SIRT1 to activate AMPK (Price et al., 2012). Epigenetic modifications, unlike genetic changes, are usually reversible. Synthetic STACS have also been demonstrated to exert beneficial cardiovascular effects on healthy cigarettes smokers (Venkatasubramanian et al., 2013).
Activation of Sirt6-dependent deacetylation can be achieved with fatty acids, and competition experiments implicated the enzymes long acyl-binding channel as a binding site.35 This activating effect required several hundred M fatty acid concentrations, however, and only more recently, pyrrolo[1,2-a]quinoxaline-derived compounds were discovered as first potent Sirt6 activators.36 These compounds increase Sirt6-dependent deacetylation of peptide substrates, histone proteins, and complete nucleosomes. Iachettini and colleagues reported that UBCS039-mediated activation of autophagy was strictly dependent on SIRT6 deacetylating activity. Given their beneficial effects in promoting longevity, sirtuin family proteins are a very interesting drug target. A considerable amount of data has accumulated on treating humans with potential STACs with inconclusive results [9093]. In this regard, a specific amino acid in SIRT1 required for STAC-mediated activation has recently been identified. These questions are worth pursuing in phase 1 clinical trials. Also, mice lacking the NAD+-consuming enzyme CD38 have increased cellular NAD+ and SIRT1 activity in several metabolically active tissues (Barbosa et al., 2007). Another strategy to modulate sirtuin activity in hematologic malignancies is by inhibiting endogenous breakdown of NAD+.
Two opposing models have been proposed to account for STAC activity: (1) direct allosteric activation of SIRTs through the lowering of peptide substrate Km, and/or (2) indirect activation resulting from off-target effects [258261].
Based on the earlier studies of sirtuin 1 and its activation by resveratrol, a number of small molecule SIRT1 activators have been synthesized and are currently being tested.63 Sirtuin-activating compounds (STACs) exert their effect by allosteric activation of this deacetylase. For example, in a mouse model of T2D, NMN supplementation mitigates negative metabolic effectsinsulin insensitivity, glucose intolerance, and inflammationof age-related or diet-induced diabetes, potentially due to the activation of SIRT1 and other sirtuins, and their downstream target pathways (Yoshino et al., 2011). One difficulty with the use of RSV in vivo is that it has significant off-target effects (Baur, 2010a). However, SRT2104 has been limited by poor and variable pharmacokinetics after oral intake. Reduced NAD+ levels induced by advanced age, caloric excess, or a sedentary lifestyle would impair activity of sirtuins and other NAD+-dependent cellular processes. markus maute ageing
As research on SIRTs progressed over the years, synthetic STACs were also developed. In mouse studies, flavonoids (e.g., quercetin, apigenin, and luteolindin) and thiazoloquin(az)olinones inhibit CD38 and cause an increase in NAD+ levels [266268]. Although increased evidence indicates RSV to be an effective SIRT1 activator with anticancer properties, its poor solubility, low bioavailability, rapid elimination, and unwanted toxicity effects are the major factors that limit its development as a cancer drug candidate [281].
To date, several epigenetic modifiers are in the market or currently under clinical trial, including HDAC inhibitors (HDACi), HAT inhibitors (HATi), protein arginine methyltransferase inhibitors (PRMTis), DNA methyltransferase inhibitors (DNMTis), histone demethylating inhibitors (HDMis), and. ScienceDirect is a registered trademark of Elsevier B.V. ScienceDirect is a registered trademark of Elsevier B.V. Complementary and Alternative Therapies and the Aging Population, Pharmacological Approaches for Modulating Sirtuins, Introductory Review on Sirtuins in Biology, Aging, and Disease, The bifunctional roles of sirtuins and their therapeutic potential in cancer, Sirtuin Biology in Cancer and Metabolic Disease, Sirtuins, Healthspan, and Longevity in Mammals, Handbook of the Biology of Aging (Eighth Edition), High-throughput screens have been conducted to identify small molecule, Baur and Sinclair, 2006; Kaeberlein et al., 2005; Pacholec et al., 2010; Park et al., 2012, Barger et al., 2008a,b; Pearson et al., 2008, Miller et al., 2011; Pearson et al., 2008, Baur and Sinclair, 2006; Kaeberlein et al., 2005; Pacholec et al., 2010, Metabolic Alterations at the Crossroad of Aging and Oncogenesis, International Review of Cell and Molecular Biology. Thus further evaluation of STACs activity in a cancer-specific manner is required. Next, the coadministration of a HDAC inhibitor with a sirtuin inhibitor results in synergy of their cytotoxicity in primary AML and CLL samples and the following cell lines: U937 (AML), 697 (pre-B-cell leukemia), and Jurkat (acute T-cell leukemia). In mice and nonhuman primates fed a high-fat diet, resveratrol protects against the effects of obesity and age-related metabolic decline, increases insulin sensitivity and mitochondrial functions, and prevents liver steatosis (Baur et al., 2006; Fiori et al., 2013; Jimenez-Gomez et al., 2013). These mice are highly resistant to weight gain in response to a HFD relative to controls.
These STACs activate SIRTs allosterically [235]. These compounds include biguanides such as metformin, which targets the AMPK and insulin signaling pathways; resveratrol, which partially affects sirtuin activity; and rapamycin, which interacts with mTOR signaling. Acetyl peptide (beige) and NAD+ (yellow) were modeled to indicate their binding sites. A number of clinical trials involving resveratrol showed benefits in glucose metabolism and cardiovascular disease risk factors [263,264], but many others have shown little to no benefits [265]. (C) Crystal structure of Sirt1 in complex with FdL peptide (beige) and three resveratrol molecules (cyan) around its fluorophore (PDB entry 4BTR).
sirtuin Ryan A. Denu, in Sirtuin Biology in Cancer and Metabolic Disease, 2021. A sustained activation of SIRT6 as a result of UBCS039 treatment also resulted in autophagy-related cell death [287]. The SIRT1-specific activator SRT1720 induces apoptosis of multiple myeloma cells [238].
5.2D).36 The structures together with first structureactivity relationship analyses indicate a key role in binding for the compounds pyridine substituents, which occupy a Sirt6 pocket that branches off from the acyl channel. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransfereases (NMNATs). It will be interesting to see how these affect sirtuin signaling in hematologic malignancies. Consistent with the observed binding mode, the compounds activate Sirt6 only against acetylated substrate and instead show competition against substrate carrying the longer myristoyl modification that requires these Sirt6 regions for binding, indicating the exciting possibility to develop acyl-specific Sirt6 modulators. Figure 6.2.
NAD+ is broken down by CD38, poly ADP-ribose polymerase 1 (PARP1), and sterile alpha and TIR motif containing protein 1 (SARM1). Therefore, targeting HDAC3 by developing an isoform-specific HDAC3 inhibitor might be an effective therapeutic intervention for diabetes and its complications, as well as inflammation [103]. Figure 3.6. Expression of SIRT1 was suppressed in these two cancer cell lines due to hypoxic stress, thus promoting EMT. Firstly regarding activators, the study of resveratrol sensitivity of cancer cell lines found a marked degree of variability based on cell type. Going through each of the seven sirtuins above, I have tried to highlight potential therapeutic opportunities. SRT2104 protects against experimentally induced muscle atrophy in wild-type mice, and muscle-specific Sirt1 knockdown in vivo accelerates muscle loss. In the setting of DNA damage, PARPs consume NAD+ to help repair DNA, but this probably reduces sirtuin activity. Huang et al. In mice, RSV treatment stimulates mitochondrial function, activates AMPK and increases NAD+ levels. Michael S. Goligorsky, in Kidney Transplantation, Bioengineering and Regeneration, 2017, The more traditional therapeutics acting on EPCs and endothelial cells belong to categories of ACE inhibitors, aldosterone inhibitors and statins, as has been exhaustively described in the past.46. Further investigation will need to discern the nature of their seemingly contradictory oncogenic and tumor-suppressive functions. (A) Crystal structure of Sirt5 in complex with FdL peptide (blue) and resveratrol (gray; PDB entry 4HDA). Promising CR mimetics with properties of cardiovascular protection include compounds that intersect with the critical signaling pathways identified above. PARP inhibitors increase NAD+ levels, which in theory could activate sirtuins.
-KA1366-img0001.jpg)
sirtfood happier scientifically proven Moreover, vorinostat (THS-785 and ITF2357) has been shown to diminish IL-1b expression and to prevent -cell loss in diabetic settings [100,101]. The more commonly known synthetic STACs which are commercially available and reported to target cancer include SRT1720, SRT3025, SRT1460, SRT2183, and UBCS039 [235,267270]. RSV supplementation shifts the gene expression pattern observed in mice on a HFD toward a profile associated with a standard diet.
Although some mechanistic details still remain to be clarified, the first synthetic STACs have entered clinical trials for evaluation as therapeutic Sirt1 activators against inflammatory and metabolic disorders.26. An increase in the cellular NAD+/NADH ratio will increase sirtuin activity. Synthetic activators such as SRT1720 and SRT2104 improve the metabolic profile and extend life span and health span of mice under a high-fat and normal diet (Mitchell et al., 2014; Minor et al., 2011). Microarray analysis revealed that SRT2104 likely has anti-inflammatory properties in skeletal muscle tissue, evidenced by a decrease in expression of NF-B target genes. As many sirtuins have been shown to play tumor-suppressive roles, one might reason that chronic DNA damage over the life span, such as from smoking, UV light, and other environmental pollutants, may reduce sirtuin activity. Concerns have been raised as to whether these polyphenols actually directly activate SIRT1 (Baur and Sinclair, 2006; Kaeberlein et al., 2005; Pacholec et al., 2010; Park et al., 2012). It will be interesting to see how newer, more potent, and more orally bioavailable sirtuin modulators evolve.
These synthetic STACs are potent SIRT1 activators with 800- to 1000-fold efficacy compared to RSV [259,267]. Resveratrol also shows benefit in improving insulin sensitivity in nonhuman primates [259]. RSV has been found in many plants, such as cranberries, grapes, peanuts, and Japanese giant knotweed [271]. (B) Crystal structure of Sirt1 in complex with a STAC (cyan; PDB entry 4ZZH). Interestingly, the compounds show no effects against Sirt1, 2, and 3, as expected from the Sirt6-specific binding site, but stimulate Sirt5s desuccinylase activity.36 The molecular basis of this Sirt5 effect remains to be characterized, but it shows that the Sirt6 activators and the structures of Sirt6/activator complexes will now have to be exploited for further development to obtain highly specific Sirt6 modulators. This section will summarize preclinical and clinical studies of sirtuin modulators and discuss some of the most impactful future avenues of investigation.
NBMs supply precursors for NAD+ synthesis. Yeuan Ting Lee, Chern Ein Oon, in Sirtuin Biology in Cancer and Metabolic Disease, 2021. Besides, RSV has been shown to alleviate EMT processes in lung and ovarian cancer in vitro and in vivo [279,280].
NMN, NR supplementation, CR or physical activity increases cellular NAD+ levels. Given their beneficial effects in promoting longevity, sirtuin family proteins are a very interesting drug target. .
UBCS039 is a newly synthesized pyrrolo[1,2-a]quinoxaline derivative, the first synthetic SIRT6 activator [286]. STACs are allosteric modulators of SIRT1 that bind to a site on the protein other than the active site to induce a conformational change that increases the activity of the enzyme.

Cells bearing a SIRT1 mutant at this site do not show the increased mitochondrial copy number and ATP content normally induced by STAC treatment (Hubbard et al., 2013).
Spermidine is a naturally occurring polyamine that is reported to counteract age-related hyperacetylation of histones due to age-dependent reduction in polyamine metabolism [98]. A Japanese epidemiologic study demonstrated that a polyamine-rich traditional Japanese food called fermented soybeans showed significant enhancement of polyamine concentration in the blood of the participants without any obvious adverse effects [101]. The increased availability of NAD+ and subsequent increased SIRT1 activity in the setting of PARP inhibition could result in greater repression of p53, which may partially reverse the efficacy of the PARP inhibitor. Pharmacological sirtuin activation. Copyright 2022 Elsevier B.V. or its licensors or contributors. This study also reported that RSV treatment induces autophagy through SIRT1/S6K pathways and inhibits the incidence of precursor lesions of prostate cancer through the Akt/mTOR signaling pathway [277].
In addition, resveratrol delays the onset of neurodegeneration and improves learning and memory in aged mice (Graff et al., 2013; Zhao et al., 2013). The in vivo study of MDL-800 in a HCC tumor xenograft model and in SIRT6 KO mice also demonstrated a significant impediment of tumor growth by activating the deacetylase activity of SIRT6 [288]. The sirtuin inhibitors tenovin-1 and tenovin-6 show activity in models of a number of hematologic malignancies, including ALL [37], DLBCL [257], and cutaneous T cell lymphoma [45]. Among these epigenetic modifiers, valproic acid, sodium phenylbutyrate, vorinostat, givinostat, and curcumin are HDACi; resveratrol is a STACs; AMI-1 is a PRMTis; tranylcypromine is part of HDMis; and hydralazine, procainamide, RG108, and MG98 belong to DNMTis [98]. In comparison, these drugs were poorly active in healthy PBMCs [52].
In contrast, two more recent meta-analysis on randomized controlled clinical studies failed to show beneficial effects on cardiovascular risk factors [91,92]. Additionally, treatment with SRT1720 synergizes with an inhibitor of the K3K79 methyltransferase, DOT1L, in mixed lineage leukemia (MLL)-rearranged leukemia cells [258]. Interestingly, there is evidence that modulating sirtuin activity could help prevent graft versus host disease (GVHD), one of the major and devastating complications associated with BMT. Dietary restriction, which induces SIRT1, acts via mTOR signaling and nicotine amide dinucleotide (NAD)dependent pathways accompanied by a shift toward oxidative metabolism,88 both representing novel modes of rejuvenation therapy. Another venue for rejuvenation therapy is based on the series of findings implicating mTOR activation and the resulting defect in autophagy in senescence.
An interesting question is how much of the carcinogenic effect of these exposures is conferred by the theoretical reduced sirtuin activity. Furthermore, another study also reported an enhanced effect when SRT1720 was used in combination with dexamethasone or bortezomib [269,283]. (A) STACs resveratrol and SRT1720; (B) NAD+ precursors nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN); (C) Potential nicotinamide phosphoribosyltransferase (NAMPT) activator P7C3 and CD38 inhibitor apigenin. Interestingly, the resveratrol effect on Sirt5 also depends on the acyl modification, since resveratrol activated Sirt5-dependent FdL deacetylation but inhibited Sirt5-dependent FdL desuccinylation.32. Alternatively, resveratrol may first activate sirtuin 1 in vivo, leading to AMPK activation via deacetylation and activation of the AMPK kinase LKB1 (Hou et al., 2008; Lan et al., 2008).
In the context of CD38-deficient mice, protection against weight gain was lost when animals were treated with a sirtuin inhibitor, implicating sirtuin activation in this effect. However, SRT1720 has also been reported to promote breast cancer metastasis [274], suggesting that the effects of STACs may function in the opposite manner. However, clinical trials to date have been less promising than the preclinical studies. Wang and colleagues have previously shown that in vivo SIRT1+/; p53+/ mice xenograft models with different malignancy types (i.e. A variety of stilbene derivatives with modifications at the 4 position of the B ring of resveratrol were synthesized that have lower toxicity and higher potency with respect to SIRT1 activation and lifespan extension in budding yeast, showing for the first time that it is possible to improve upon naturally occurring STACs.3. Known pharmacological agents that target these substrates and enzymes to increase NAD+ levels are marked on the figure in black, or indicated with gray arrows. STACs include, in addition to resveratrol, quercetin and butein (first generation); SRT 1720, 1460, and 2183 (second generation); and STAC-5, -9, and -10 (third generation), all extending life-span and/or health-span. Allosteric sirtuin activation with small molecules, with the goal of promoting healthspan and longevity, has been an area of intense investigation. Phenotypes resulting from increased NAD+ levels must be rigorously elucidated in model organisms before use of these non-allosteric approaches can be attempted in humans. The anticancer roles of RSV have been widely studied and indicate that RSV can inhibit tumorigenesis by inducing S-phase cell cycle arrest and apoptosis, as well as inhibiting metastasis, aromatase, and angiogenesis in liver, breast, prostate, leukemia, skin, and myeloma cancer cells [271,272].
Alternatively, synthetic STACs such as SRT2170 and SIRT1460 have been synthesized to overcome the RSV limitation. Moreover, in rhesus monkeys, under a high-fat and high-sugar diet, resveratrol exerts antiinflammatory effects in visceral white adipose tissue (Jimenez-Gomez et al., 2013). SIRT1 STACs, SRT2183, and SRT501 have demonstrated significant inhibition of growth and induction of apoptosis in malignant lymphoid cell lines. Also, SIRT1-dependent stimulation of osteogenic differentiation by SRT2104 treatment was reported using myoblast cell cultures, suggesting SRT2104 activates SIRT1 to protect against age-related muscle loss and osteoporosis. These studies initially identified resveratrol (RSV) and other polyphenols as SIRT1 activators (Howitz et al., 2003); subsequent studies have identified a large series of artificial, higher-potency STACs. In cancer, resveratrol for 45 weeks reduces prostate cancers by about 50% in mice [260].
This shift occurs in parallel with improved overall health, insulin sensitivity, increased mitochondrial content, and maintenance of motor function (Barger et al., 2008a,b; Pearson et al., 2008).